Cathie Wood’s ARK Invest Sells Over 840,000 Shares of Seres Therapeutics
One of Cathie Wood's ARK Invest exchange-traded funds sold over 840,000 shares of Seres Therapeutics on August 30.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood sold over 840,000 shares of Seres Therapeutics Inc. (NASDAQ: MCRB) shares on Monday, as the price of this ETF was up nearly 1% in Monday’s session. The fund is up significantly in the past year.
ARK Innovation ETF (NYSEARCA: ARKK) sold 846,468 shares of Seres Therapeutics. At Monday’s closing price, this would have valued this sale at roughly $5.2 million. This is only a small fraction of the total holdings. This ETF is up 35% over the past 52 weeks.
Here are all the ARK Invest sales on Monday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | 6060HK | ZHONGAN ONLINE P&C INSURANCE | 981,100 |
| ARKF | 9923HK | YEAHKA | 297,200 |
| ARKG | PSTI | PLURISTEM THERAPEUTICS | 10,518 |
| ARKG | CLLS | CELLECTIS | 7,300 |
| ARKG | RHHBY | ROCHE | 78,900 |
| ARKK | MCRB | SERES THERAPEUTICS | 846,468 |
| ARKK | IOVA | IOVANCE BIOTHERAPEUTICS | 71,749 |
| ARKQ | ISRG | INTUITIVE SURGICAL | 1,700 |
| ARKQ | NXPI | NXP SEMICONDUCTORS | 13,000 |
| ARKQ | BABA | ALIBABA | 15,089 |
| ARKQ | GOOG | ALPHABET | 4,808 |
| ARKW | MELI | MERCADOLIBRE | 4,500 |
| ARKW | SE | SEA | 34,049 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Contact [email protected] for any questions or corrections.






